Correlation Between Vaccinex and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Vaccinex and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and SAB Biotherapeutics, you can compare the effects of market volatilities on Vaccinex and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and SAB Biotherapeutics.
Diversification Opportunities for Vaccinex and SAB Biotherapeutics
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Vaccinex and SAB is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Vaccinex i.e., Vaccinex and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Vaccinex and SAB Biotherapeutics
Given the investment horizon of 90 days Vaccinex is expected to generate 1.14 times less return on investment than SAB Biotherapeutics. In addition to that, Vaccinex is 1.05 times more volatile than SAB Biotherapeutics. It trades about 0.04 of its total potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.05 per unit of volatility. If you would invest 292.00 in SAB Biotherapeutics on August 28, 2024 and sell it today you would earn a total of 5.00 from holding SAB Biotherapeutics or generate 1.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vaccinex vs. SAB Biotherapeutics
Performance |
| Timeline |
| Vaccinex |
| SAB Biotherapeutics |
Vaccinex and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaccinex and SAB Biotherapeutics
The main advantage of trading using opposite Vaccinex and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Vaccinex vs. Eliem Therapeutics | Vaccinex vs. Scpharmaceuticals | Vaccinex vs. Milestone Pharmaceuticals | Vaccinex vs. Seres Therapeutics |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |